COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.
Kristin M D'SilvaApril M JorgeAndrew CohenNatalie McCormickYuqing ZhangZachary S WallaceHyon K ChoiPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2021)
Our findings indicate that COVID-19 patients with systemic ARDs may be at a higher risk of hospitalization, ICU admission, acute renal failure, and venous thromboembolism when compared to COVID-19 patients without systemic ARDs. These risks may be largely mediated by comorbidities, except for the risk of venous thromboembolism.
Keyphrases
- venous thromboembolism
- sars cov
- mechanical ventilation
- direct oral anticoagulants
- acute respiratory distress syndrome
- drug induced
- extracorporeal membrane oxygenation
- coronavirus disease
- emergency department
- respiratory failure
- intensive care unit
- multiple sclerosis
- respiratory syndrome coronavirus
- clinical trial
- cross sectional
- aortic dissection
- skeletal muscle
- double blind